MedPath
FDA Approval

Ticagrelor

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 15, 2025
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ticagrelor(90 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Sunshine Lake Pharma Co., Ltd.

545391443

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Sunshine Lake Pharma Co., Ltd.

Oryza Pharmaceuticals, Inc.

Sunshine Lake Pharma Co., Ltd.

545391443

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ticagrelor

Product Details

NDC Product Code
72516-018
Application Number
ANDA208508
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 15, 2025
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
Code: GLH0314RVCClass: ACTIBQuantity: 90 mg in 1 1

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


RECENT MAJOR CHANGES SECTION


DESCRIPTION SECTION

CLINICAL PHARMACOLOGY SECTION


INDICATIONS & USAGE SECTION

DOSAGE & ADMINISTRATION SECTION

DOSAGE FORMS & STRENGTHS SECTION


CONTRAINDICATIONS SECTION

BOXED WARNING SECTION

WARNINGS AND PRECAUTIONS SECTION


DRUG INTERACTIONS SECTION


USE IN SPECIFIC POPULATIONS SECTION


ADVERSE REACTIONS SECTION

CLINICAL STUDIES SECTION


OVERDOSAGE SECTION


NONCLINICAL TOXICOLOGY SECTION


INFORMATION FOR PATIENTS SECTION

SPL MEDGUIDE SECTION


HOW SUPPLIED SECTION


© Copyright 2025. All Rights Reserved by MedPath